Bibliometric Analysis and Visualization of Research Trends on HIV-1 Capsid Inhibitors (2000–2022)
October 2023
in “
Frontiers in Pharmacology
”
TLDR Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.
This bibliometric analysis of HIV-1 capsid inhibitors research from 2000 to 2022 highlights significant progress and increasing publication trends in this field. The study included 96 publications from 25 countries, with the United States leading in productivity, citations, and international collaboration. Drexel University and Simon Cocklin were identified as the most prolific institution and author, respectively. Key research areas include the molecular mechanisms of capsid proteins, drug candidate discovery, and enhancement of antiretroviral therapy. This first comprehensive bibliometric study aims to provide insights to advance HIV-1 capsid inhibitor research.